233
Participants
Start Date
October 6, 2021
Primary Completion Date
January 12, 2022
Study Completion Date
April 25, 2022
Ingavirin®, 90 mg capsules
90-180 mg/day for 7 days on top of standard therapy
Placebo
1-2 capsules for 7 days on top of standard therapy
"State Budgetary Institution of Healthcare of Moscow City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow
Unimed-C Jsc, Moscow
Ivanovo Kuvaev Clinical Hospital, Ivanovo
"Limited Liability Company Medical Center Capital-Policy", Saint Petersburg
"Saint Petersburg State Budgetary Healthcare Institution City polyclinic No. 112", Saint Petersburg
"Limited Liability Company Research Center Eco-Safety", Saint Petersburg
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 117", Saint Petersburg
"Saint Petersburg State Budgetary Institution of Healthcare City Pokrovskaya Hospital", Saint Petersburg
Astarta LLC, Saint Petersburg
"Municipal Budgetary Institution of Healthcare Central City Hospital of Novoshakhtinsk", Novoshakhtinsk
"4D Ultrasound Clinic LLC", Pyatigorsk
Ryazan State Medical University named after Academician I.P. Pavlova, Ryazan
"State Budgetary Institution of the Ryazan Region Regional Clinical Hospital", Ryazan
"Family Clinic LLC", Yekaterinburg
Valenta Pharm JSC
INDUSTRY